Progress of the smart bomb cancer virus

Nature Medicine

Volumn 3, Issue 6, 1997, Pages 606-608

  Lowe, Scott W ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS; ONCOPROTEIN; PROTEIN P53;

ADENOVIRUS; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER CELL; CANCER GENETICS; CANCER RESEARCH; CANCER THERAPY; CELLULAR IMMUNITY; CYTOTOXICITY; DNA DAMAGE; GENE THERAPY; GENE TRANSFER; PRIORITY JOURNAL; SHORT SURVEY; TUMOR CELL; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; ANIMALS; GENE THERAPY; MICE; MICE, NUDE; MUTATION; NEOPLASMS, EXPERIMENTAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031006629     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0697-606     Document Type: Short Survey

References (10)

1. Bischoff, J. R. et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373-376 (1996).
2. Heise, C. et al. ONXY-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Med. 3, 639-645 (1997).
3. Weinberg, R. A. The cat and mouse games that genes, viruses, and cells play. Cell 88, 573-575 (1997).
4. Lowe, S. W. & Ruley, H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus E1A and accompanies apoptosis. Genes Dev. 7, 535-545 (1993).
5. Grand, R. J. A., Grant, M. L. & Gallimore, P. H. Enhanced expression of p53 in human cells in fected with mutant adenoviruses. Virology 203, 229-240 (1994).
6. Debbas, M. & White, E. Wildtype p53 mediates apoptosis by El A, which is inhibited by E1B. Genes Dev. 7, 546-554 (1993).
7. Yew, P. R. & Berk, A. J. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357, 82-85 (1992).
8. Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 954-967 (1993).
9. Somasundaram, K. & El-Deiry, W. S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047-1057 (1997).
10. Dobner, T., Horikoshi, N., Rubenwolf, S. & Shenk, T. Blockage by adenovirus E41orf6 of transcriptional activation by the p53 tumor suppressor. Science 272, 1470-1473 (1996).